Clinical Trial Update: Study Investigating Anti-drug Antibodies in NSCLC Patients Exposed to Checkpoint Inhibitors (IMB)

View source ↗

Summary

A clinical trial update notes an ongoing study investigating anti-drug antibodies in non-small cell lung cancer patients treated with checkpoint inhibitors. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Fondazione Ricerca Traslazionale | Conditions: NSCLC | Status: RECRUITING